Educational research tool. Not investment advice. You are responsible for your own trading decisions.

Verdix.
← All analysis

Applied Materials, Inc. (AMAT)

Verdict history · AMAT

Every call Verdix has made on AMAT.

While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.

See methodology for how verdicts are produced. Full track record →

Why the panel isn’t ready to call AMAT yet — and where they disagree.

WaitHIGH confidence

A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.

NASDAQ · Information Technology / Semiconductor Equipment · 2026-08-15 · analysis, not advice

Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.

Verdict

Wait

HIGH confidence

Why

Applied Materials commands a wide moat, fortress balance sheet, and 36% ROIC at the center of the AI infrastructure buildout, but all five analyst voices on the panel agree the stock is simply too expensive at 44x trailing earnings. The debate splits between those who see a pullback as inevitable before new money should enter and those who believe the secular tailwind will eventually grow into the multiple, with a fair-value consensus clustering near $450–$475.

Level to watch

Key resistance 516

+1.7% from 507.18

Next catalyst

Price to signal the dip is over: A weekly close above $516 — the 38.2% Fibonacci retracement of the multi-year range — with the weekly MACD histogram turning positive would confirm that momentum has resumed and the post-earnings correction was a shakeout, not a trend reversal.

The panel's take

Verdict: WAIT · Conviction: HIGH · Last price: 507.18

This is a textbook BUY vs WAIT split: every voice affirms the business quality (wide moat, 36% ROIC, net cash, secular AI tailwind), but all five cautious voices — across technical, fundamental, quantitative, contrarian, and The Moat Compounder lenses — object solely on price. No voice disputes the business itself. A WAIT verdict is required when the blocker is entry price, not thesis quality. Calling this BALANCED would be wrong because the split is not genuine business disagreement; it's unanimous that AMAT is a wonderful company at the wrong price for new money.

Key levels

Key levels · AMAT

USD · as of 2026-08-15
Analyst consensus 507.18
R3740
+45.9%
R2582
+14.8%
R1516
+1.7%
S1484
−4.6%
S2447
−11.9%
S3400
−21.1%
NOW
507.18

Analyst consensus target 507.18 USD · range 507.18507.18

Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.

What legendary investors think

We ran Applied Materials, Inc. past a panel of 5 legendary investors' frameworks.

The panel · 5 investors

🟢
0
Bullish
5
Neutral
🔴
0
Bearish
The Intrinsic-Value ModelerValuation/DCF NeutralMed

Signal: A DCF anchored to 20% revenue growth for three years, a 32% steady-state operating margin, and a 10% WACC yields an equity value of roughly $475 per share, leaving no margin of safety at the current $508 price for a cyclical business that Morningstar itself rates High Uncertainty. Conviction: Conviction firms up because three independent valuation approaches converge near $470 — Morningstar's fair value, a conservative DCF, and the normalized-cycle framework all point to the same neighborhood, making the overvaluation signal harder to dismiss.

The GARP OperatorGrowth (GARP) NeutralMed

Signal: The forward PEG ratio lands at 1.7 using Morningstar's 17% long-term growth forecast, and while that is acceptable for a 36% ROIC business with a net-cash balance sheet, the weekly MACD bearish cross arriving right after a beat-and-raise quarter that the stock sold off on is the classic signature of an over-owned name entering an intermediate correction. Conviction: Conviction is tempered by one contested assumption: that the AI-driven equipment cycle will sustain 17% growth long enough to grow into the current multiple, and the MACD rollover directly challenges whether the market still believes that.

The Moat CompounderValue/Quality/Moat NeutralMed

Signal: Applied Materials holds a genuine moat — proprietary equipment design, embedded services with 95%-plus retention, and switching costs that make retooling a fab a multi-billion-dollar decision — yet the trailing P/E of 44x sits more than double the stock's five-year average of 20–25x, so you are paying for a decade of perfect harvests before the first seed is in the ground. Conviction: Confidence in waiting is reinforced by multiple independent signals: the CFO walking back the 2028 capacity-to-revenue extrapolation, the sell-off on a beat, and a valuation that even generous DCFs cannot stretch to justify.

The Forensic SkepticContrarian/Forensic NeutralMed

Signal: Gross margins are dead flat at 50.4% despite 51% year-over-year revenue growth, which means operating leverage is not materializing even as the company hires 1,500 people in a single quarter — the margin expansion that justifies a 44x multiple is absent, and the CFO openly told analysts not to extrapolate the capacity-doubling narrative into 2028 revenue. Conviction: Conviction that risk outweighs reward is held back by one factor: AMAT's balance sheet is a fortress with $2.7 billion in net cash and free cash flow conversion at 90%, so a deep value floor exists somewhere below, even if the current price is nowhere near it.

The Disruptive-Innovation SeekerDisruptive Innovation NeutralMed

Signal: Wright's Law does not directly apply, but the Moore's Law derivative is powerful: each new process node demands 30–40% more wafer-fab equipment per wafer, and AMAT is the only supplier covering roughly 85% of semiconductor manufacturing steps, positioning it as the ultimate pick-and-shovel enabler across AI training, edge inference, and advanced packaging — three S-curves that are still in the early majority phase. Conviction: Long-term conviction is dented by a single near-term reality: the 183% 12-month run has already pulled forward much of the five-year base case, and the 6% post-earnings drop on a beat-and-raise quarter confirms that sentiment, not fundamentals, now drives the stock.

Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.

Where they agree — and where they clash

Common ground

  • All five voices affirm that Applied Materials is a genuinely wonderful business: a wide and durable moat built on proprietary equipment, embedded services, and switching costs that make retooling prohibitive.
  • Every archetype points to the same financial bedrock: 36% ROIC, 90%-plus free cash flow conversion, $2.7 billion in net cash, and a debt-to-equity ratio of 0.26.
  • None of the five voices disputes the secular AI tailwind; WFE spending at roughly $150 billion is accepted as a structural, multi-year demand driver.
  • All five converge on a fair-value zone in the $450–$475 range, whether derived from DCF, normalized P/E, Morningstar's estimate, or Fibonacci levels.

The real debate

  • The Disruptive-Innovation Seeker sees the flat gross margin and aggressive hiring as long-term capacity-building that should be rewarded, while The Forensic Skeptic reads those same facts as a near-term earnings headwind that keeps the 44x multiple indefensible today.
  • The GARP Operator flags the weekly MACD bearish cross as a timing signal to wait for a correction, but The Moat Compounder reaches the same wait conclusion purely on valuation grounds — the debate is whether price or technicals should dictate the entry trigger, and both land in the same place.
  • The Intrinsic-Value Modeler treats a 10% WACC as generous for a high-quality cyclical while The Forensic Skeptic insists that cyclicality demands a larger discount, making the gap between $475 and $440 a genuine philosophical divide about how much safety a cyclical deserves.

The question it comes down to: Will Applied Materials grow into its 44x trailing multiple before the semiconductor equipment cycle turns, or will the cycle expose that price before the secular AI story has time to compound?

The bottom line

  • Price to signal the dip is over: A weekly close above $516 — the 38.2% Fibonacci retracement of the multi-year range — with the weekly MACD histogram turning positive would confirm that momentum has resumed and the post-earnings correction was a shakeout, not a trend reversal.
  • Accumulation zone to watch: A pullback into the $450–$475 range, where Morningstar's fair value, The Intrinsic-Value Modeler's DCF, and the monthly 38.2% Fib all cluster, would materially change the balance of upside to downside and likely convert the panel's WAIT to BUY.
  • Gross margin to monitor: If gross margins fail to expand past 52% by the second half of fiscal 2027 — despite the capacity investments made now — the operating-leverage thesis collapses and the 44x trailing multiple becomes impossible to defend on fundamentals alone.
  • Cycle-warning indicator: Any downward revision to WFE spending guidance from AMAT's largest customers, or a sustained inventory build at chipmakers, would signal that the $150 billion WFE cycle is peaking and trigger the multiple compression every archetype fears.

contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · No direct position held in AMAT · AMAT verdict history → · Methodology →

Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.

Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.

Stay ahead of AMAT's next verdict

The panel's view can flip on new earnings, a guidance cut, or a valuation shift. Get the update the moment it happens — not weeks later.

One email, only on a verdict change. Unsubscribe anytime.